The Food and Drug Administration took a key step this week toward making children ages 5 to 11 eligible for COVID-19 vaccines, as an advisory committee endorsed a child-size dose of the two-shot Pfizer vaccination.

The panel unanimously agreed that the vaccine’s benefits outweigh any possible…